310 related articles for article (PubMed ID: 10808206)
1. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
[TBL] [Abstract][Full Text] [Related]
2. Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group.
Denning DW; Donnelly JP; Hellreigel KP; Ito J; Martino P; van't Wout JW
Chemotherapy; 1992; 38 Suppl 1():43-9. PubMed ID: 1611930
[TBL] [Abstract][Full Text] [Related]
3. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.
Wingard JR; Merz WG; Rinaldi MG; Johnson TR; Karp JE; Saral R
N Engl J Med; 1991 Oct; 325(18):1274-7. PubMed ID: 1669837
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
Goodman JL; Winston DJ; Greenfield RA; Chandrasekar PH; Fox B; Kaizer H; Shadduck RK; Shea TC; Stiff P; Friedman DJ
N Engl J Med; 1992 Mar; 326(13):845-51. PubMed ID: 1542320
[TBL] [Abstract][Full Text] [Related]
5. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias.
Schaffner A; Schaffner M
J Infect Dis; 1995 Oct; 172(4):1035-41. PubMed ID: 7561177
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients.
Perfect JR; Klotman ME; Gilbert CC; Crawford DD; Rosner GL; Wright KA; Peters WP
J Infect Dis; 1992 May; 165(5):891-7. PubMed ID: 1569339
[TBL] [Abstract][Full Text] [Related]
7. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
8. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
[TBL] [Abstract][Full Text] [Related]
9. A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia.
Rozenberg-Arska M; Dekker AW; Branger J; Verhoef J
J Antimicrob Chemother; 1991 Mar; 27(3):369-76. PubMed ID: 2037541
[TBL] [Abstract][Full Text] [Related]
10. Australian Dental Research Fund Trebitsch Scholarship. Efficacy of antifungal prophylaxis in bone marrow transplantation.
Quirk PC; Osborne PJ; Walsh LJ
Aust Dent J; 1995 Aug; 40(4):267-70. PubMed ID: 7575286
[TBL] [Abstract][Full Text] [Related]
11. Antifungal prophylaxis in bone marrow transplantation.
Milliken ST; Powles RL
Rev Infect Dis; 1990; 12 Suppl 3():S374-9. PubMed ID: 2184515
[TBL] [Abstract][Full Text] [Related]
12. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation.
Rousey SR; Russler S; Gottlieb M; Ash RC
Am J Med; 1991 Nov; 91(5):484-92. PubMed ID: 1951410
[TBL] [Abstract][Full Text] [Related]
13. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients.
Chopra R; Blair S; Strang J; Cervi P; Patterson KG; Goldstone AH
J Antimicrob Chemother; 1991 Oct; 28 Suppl B():93-104. PubMed ID: 1778896
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome)--a report on 40 cases from a single centre.
Chopra R; Fielding A; Goldstone AH
Leuk Lymphoma; 1992; 7 Suppl():73-7. PubMed ID: 1493462
[TBL] [Abstract][Full Text] [Related]
15. Aerosolized amphotericin B lipid complex as adjunctive treatment for fungal lung infection in patients with cancer-related immunosuppression and recipients of hematopoietic stem cell transplantation.
Safdar A; Rodriguez GH
Pharmacotherapy; 2013 Oct; 33(10):1035-43. PubMed ID: 23784915
[TBL] [Abstract][Full Text] [Related]
16. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
Am J Med; 1989 Jun; 86(6 Pt 1):668-72. PubMed ID: 2658574
[TBL] [Abstract][Full Text] [Related]
17. A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients.
Kang WH; Song GW; Lee SG; Suh KS; Lee KW; Yi NJ; Joh JW; Kwon CHD; Kim JM; Choi DL; Kim JD; Kim MS
J Gastrointest Surg; 2020 Apr; 24(4):832-840. PubMed ID: 31066013
[TBL] [Abstract][Full Text] [Related]
18. Infectious complications of human bone marrow transplantation.
Winston DJ; Gale RP; Meyer DV; Young LS
Medicine (Baltimore); 1979 Jan; 58(1):1-31. PubMed ID: 368507
[TBL] [Abstract][Full Text] [Related]
19. Management of fungal infection in neutropenic patients with fluconazole.
Brammer KW
Haematol Blood Transfus; 1990; 33():546-50. PubMed ID: 2182447
[TBL] [Abstract][Full Text] [Related]
20. Reduction of systemic fungal infections in patients with hematological malignancies, neutropenia, and prolonged fever by early amphotericin B therapy.
Zimmermann-Hösli MB; Stahel RA; Vogt P; Oelz O
Klin Wochenschr; 1988 Oct; 66(20):1010-4. PubMed ID: 3236752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
